In the present study, we hypothesized that the difference in the AngII regulation of LPL metabolism in either VAT or SAT may explain the difference in their contributions to hypertriglyceridemia, a component of metabolic syndrome. This evidence concerns the gene AGT and hypertriglyceridemia.